Intercept Pharmaceuticals, Inc. ICPT
19.00 0.00 (+0.00%)
Regular-session close
18.98 Day range 19.01
52-week range unavailable
ICPT revenue history
Revenue is income from the company’s ordinary business activities.
285,710,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | 285,710,000 | 24,960,000 | 9.57% |
| FY 2021 | 2021-12-31 | 260,750,000 | 26,780,000 | 11.45% |
| FY 2020 | 2020-12-31 | 233,970,000 | -18,032,000 | -7.16% |
| FY 2019 | 2019-12-31 | 252,002,000 | 72,198,000 | 40.15% |
| FY 2018 | 2018-12-31 | 179,804,000 | 48,848,000 | 37.30% |
| FY 2017 | 2017-12-31 | 130,956,000 | 106,005,000 | 424.85% |
| FY 2016 | 2016-12-31 | 24,951,000 | 22,169,000 | 796.87% |
| FY 2015 | 2015-12-31 | 2,782,000 | 1,040,000 | 59.70% |
| FY 2014 | 2014-12-31 | 1,742,000 | 120,000 | 7.40% |
| FY 2013 | 2013-12-31 | 1,622,000 | -824,105 | -33.69% |
| FY 2012 | 2012-12-31 | 2,446,105 | 640,975 | 35.51% |
| FY 2011 | 2011-12-31 | 1,805,130 | 1,805,130 | Not meaningful |
| FY 2010 | 2010-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:02:55.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.